Recombinant multi-species MYCN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYCN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
The Alternative Names of target: Class E basic helix-loop-helix protein 37 (bHLHe37),FGLDS1,MODED,MPAPA,MYCN,MYCNsORF,MYCNsPEP,Mycn,N-MYC1,N-myc,N-myc proto-oncogene protein,NMYC,Nmuc1,Nmyc,Nmyc-1,Nmyc1,ODED,bHLHe37,c-nmyc

Target products collectionGo to MYCN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T88786-Ag-1/ GM-Tg-hg-T88786-Ag-2 Human MYCN protein Human
GM-Tg-rg-T88786-Ag-1/ GM-Tg-rg-T88786-Ag-2 Rat MYCN protein Rat
GM-Tg-mg-T88786-Ag-1/ GM-Tg-mg-T88786-Ag-2 Mouse MYCN protein Mouse
GM-Tg-cynog-T88786-Ag-1/ GM-Tg-cynog-T88786-Ag-2 Cynomolgus/Rhesus macaque MYCN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T88786-Ag-1/ GM-Tg-felg-T88786-Ag-2 Feline MYCN protein Feline
GM-Tg-cang-T88786-Ag-1/ GM-Tg-cang-T88786-Ag-2 Canine MYCN protein Canine
GM-Tg-bovg-T88786-Ag-1/ GM-Tg-bovg-T88786-Ag-2 Bovine MYCN protein Bovine
GM-Tg-equg-T88786-Ag-1/ GM-Tg-equg-T88786-Ag-2 Equine MYCN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T88786-Ag-1/ GM-Tg-hg-T88786-Ag-2; GM-Tg-rg-T88786-Ag-1/ GM-Tg-rg-T88786-Ag-2;
GM-Tg-mg-T88786-Ag-1/ GM-Tg-mg-T88786-Ag-2; GM-Tg-cynog-T88786-Ag-1/ GM-Tg-cynog-T88786-Ag-2;
GM-Tg-felg-T88786-Ag-1/ GM-Tg-felg-T88786-Ag-2; GM-Tg-cang-T88786-Ag-1/ GM-Tg-cang-T88786-Ag-2;
GM-Tg-bovg-T88786-Ag-1/ GM-Tg-bovg-T88786-Ag-2; GM-Tg-equg-T88786-Ag-1/ GM-Tg-equg-T88786-Ag-2
Products Name MYCN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MYCN
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYCN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.